Conference Coverage
Conference Coverage
Bariatric surgery is most effective early in the diabetes trajectory
LOS ANGELES – But in the United States, only about 1% of eligible patients with diabetes undergo the procedure.
Conference Coverage
Treatment of heart failure with preserved ejection fraction is a work in progress
Although the disorder has a lower mortality than heart failure with reduced ejection fraction, it places a significant burden on health care...
Conference Coverage
Diabetes boosts bariatric surgery complications
LAS VEGAS – In addition, patients with insulin-dependent diabetes had significantly higher rates of these and other complications, compared with...
Conference Coverage
Carbohydrate restriction a viable choice for reversal of type 2 diabetes, expert says
LOS ANGELES – Even patients who did not experience a reversal had reductions in HbA1c and triglyceride...
Conference Coverage
Score predicts bariatric surgery’s benefits for obesity, type 2 diabetes
LAS VEGAS – The calculator can estimate the 10-year risk for death and cardiovascular disease events for patients if their clinical status...
Conference Coverage
SGLT2 inhibitors for diabetes safe, effective in older adults
BUSAN, SOUTH KOREA – Results for older patients were similar to those for younger patients.
Conference Coverage
Top picks for online diabetes information for doctors and patients
BUSAN, SOUTH KOREA – With many patients going online for information about diabetes, it is important they know which resources are most reliable...
Conference Coverage
Can insulin plus metformin improve pregnancy outcomes in women with type 2 diabetes?
WASHINGTON – A number of studies are currently tracking the impact of add-on metformin during pregnancy.
Conference Coverage
End ‘therapeutic nihilism’ in care of older diabetic patients, says expert
LOS ANGELES – ‘It’s not hyperglycemia that’s killing people; it’s heart disease and renal disease.’
Conference Coverage
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.